Product Name :
Orlistat
Sequence:
Purity:
≥97%
Molecular Weight:
495.7
Solubility :
Soluble in DMSO or 100% ethanol.
Appearance:
White to off-white solid.
Use/Stability :
As indicated on product label or CoA when stored as recommended. Stock solutions are stable for up to 6 weeks when stored at -20°C.
Description:
Fatty acid synthase inhibitor Cell permeable, irreversible inhibitor of gastric and pancreatic lipases.{{129453-61-8} site|{129453-61-8} Protocol|{129453-61-8} In Vivo|{129453-61-8} custom synthesis} Shows only minimal activity against amylase, trypsin, chymotrypsin, or phospholipase A2 (PLA2).{{2519537-70-1} web|{2519537-70-1} Purity & Documentation|{2519537-70-1} In stock|{2519537-70-1} manufacturer} Partially inhibits the hydrolysis of triglycerides and lowers the absorption of dietary fat and promotes weight loss.PMID:31194471 Anti-obesity drug. Exhibits antitumor activity by inhibition of the thioesterase domain of fatty acid synthase (FAS) both in vitro and in vivo.
CAS :
96829-58-2
Solubility:
Soluble in DMSO or 100% ethanol.
Formula:
C29H53NO5
Additional Information :
| Alternative Name Tetrahydrolipstatin, N-Formyl-L-leucine-(1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester | Appearance White to off-white solid. | CAS 96829-58-2 | Couple Target Fatty acid synthase | Couple Type Inhibitor | Formula C29H53NO5 | MI 14: 6869 | MW 495.7 | Purity ≥97% | Solubility Soluble in DMSO or 100% ethanol. | Source Synthetic. Originally isolated from Streptomyces sp. | Unit of Measure (UM) mg
